Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05
- PMID: 17885730
- DOI: 10.1007/s15010-007-6218-5
Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05
Abstract
Introduction: Influenza continues to be a considerable health problem in Europe. Vaccination is the only preventive measure, reducing mortality and morbidity of influenza in all age groups
Objectives: The objective of this survey was to assess and compare the level of influenza vaccination coverage during three consecutive influenza seasons (02/03, 03/04, 04/05) in the five European countries United Kingdom, France, Italy, Germany and Spain, understand the driving forces and barriers to vaccination now and 3 years ago and determine vaccination intentions for the following winter.
Methods: We conducted a random-sampling, telephone-based household survey among non-institutionalized individuals representative of the population aged 14 and over. The surveys used the same questionnaire for all three seasons. The data were subsequently pooled. Four target groups were determined for analysis: (1) persons aged 65 and over; (2) people working in the medical field; (3) persons suffering from chronic illness and (4) a group composed of persons aged 65 and over or working in the medical field or suffering from a chronic illness.
Results: The overall sample consisted of 28,021 people. The influenza vaccination coverage rate increased from 21.0% in season 02/03 to 23.6% in season 03/04 and then to 23.7% in season 04/05. The differences between the seasons are statistically significant (p = 0.01). The highest rate over all countries and seasons had Germany in season 04/05 with 26.5%, Spain had in season 02/03 with 19.3% the lowest rate totally. The coverage rate in the target group composed of person's aged 65 and over or working in the medical field or suffering from a chronic illness was 49.7% in season 02-04 and 50.0% in season 04/05. The driving forces and barriers to vaccination did not change over the years. The most frequent reasons for being vaccinated given by vaccines were: influenza, considered to be a serious illness which people wanted to avoid, having received advise from the family doctor or nurse to be vaccinated and not wanting to infect family and friends. Reasons for not being vaccinated mentioned by people who have never been vaccinated were: not expecting to catch influenza, not having considered vaccination before and not having received a recommendation from the family doctor to be vaccinated. Options encouraging influenza vaccination are: recommendation by the family doctor or nurse, more available information on the vaccine regarding efficacy and tolerance and more information available about the disease. The adjusted odds ratio of receiving influenza vaccine varied between 2.5 in Germany and 6.3 in the United Kingdom in any risk group.
Conclusion: The vaccination coverage rate increased from the first season (21.0%) to the third season (23.7%) by 2.6%. The family doctor is the most important source of encouragement for people to be vaccinated against influenza. It seems that the public would be more likely to be vaccinated if they had more information on the efficacy and tolerance of the vaccine, as well as the disease. We therefore suggest that family doctors be better informed on influenza vaccine and the disease itself, so that they can actively inform their patients on these topics.
Comment in
-
Influenza vaccination in Europe--still a long way to go.Infection. 2007 Oct;35(5):299. doi: 10.1007/s15010-007-7507-8. Infection. 2007. PMID: 17885727 No abstract available.
Similar articles
-
Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons.Vaccine. 2005 Oct 17;23(43):5055-63. doi: 10.1016/j.vaccine.2005.06.005. Vaccine. 2005. PMID: 16046035
-
Influenza vaccination coverage rates in Germany a population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004.Med Klin (Munich). 2005 Jan 15;100(1):6-13. doi: 10.1007/s00063-005-1113-2. Med Klin (Munich). 2005. PMID: 15654537
-
[Coverage rates of influenza vaccine in Italy during the 2002/3 and 2003/04 seasons: a cross-sectional study].Ann Ig. 2005 Jul-Aug;17(4):351-63. Ann Ig. 2005. PMID: 16156395 Italian.
-
[Prophylactic influenza vaccination: what is the situation in Germany?].Dtsch Med Wochenschr. 2006 Mar 3;131(9):453-7. doi: 10.1055/s-2006-932543. Dtsch Med Wochenschr. 2006. PMID: 16493571 Review. German.
-
Practice-proven interventions to increase vaccination rates and broaden the immunization season.Am J Med. 2008 Jul;121(7 Suppl 2):S11-21. doi: 10.1016/j.amjmed.2008.05.003. Am J Med. 2008. PMID: 18589063 Review.
Cited by
-
Absence of influenza vaccination among high-risk older adults in Taiwan.BMC Public Health. 2010 Oct 13;10:603. doi: 10.1186/1471-2458-10-603. BMC Public Health. 2010. PMID: 20942933 Free PMC article.
-
Parental Perception Towards Flu Vaccination for Asthmatic Children in Saudi Arabia.Cureus. 2019 Dec 25;11(12):e6460. doi: 10.7759/cureus.6460. Cureus. 2019. PMID: 32021734 Free PMC article.
-
Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability.Hum Vaccin Immunother. 2013 Mar;9(3):591-8. doi: 10.4161/hv.23240. Epub 2013 Jan 7. Hum Vaccin Immunother. 2013. PMID: 23295262 Free PMC article. Clinical Trial.
-
Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.Hum Vaccin Immunother. 2013 Jan;9(1):115-21. doi: 10.4161/hv.22342. Hum Vaccin Immunother. 2013. PMID: 23442585 Free PMC article. Review.
-
Outpatient-based pneumococcal vaccine campaign and survey of perceptions about pneumococcal vaccination in patients and doctors.Yonsei Med J. 2013 Mar 1;54(2):469-75. doi: 10.3349/ymj.2013.54.2.469. Yonsei Med J. 2013. PMID: 23364983 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical